The tool reviewed the files of 79,000 adult patients who had not been compliant with colorectal cancer screening. The tool determined approximately 688 men and women were at higher risk for CRC. They were recommended for further evaluation.
Physicians were notified and, in turn, followed up with their patients. Of the 688 flagged patients, 254 had a colonoscopy. From that, 19 cases of colorectal cancer were diagnosed as well as 22 advanced adenomas.
The results of the study show “this technology can successfully provide a safety net in clinical practice.”
Medial EarlySign’s CMO Ran Goshen, MD, said, “The implementation of machine learning-based algorithms to risk stratify populations at risk is commonly feared by many clinicians and population health managers as a hard-to-trust black box. In collaboration with [Tel Aviv, Israel-based Maccabi Healthcare Services], we have shown for the first time that given the correct set-up of clinical leadership and top-notch technology, obstacles and hurdles can be overcome.”
More articles on gastroenteorlogy:
10 things to know about Pinnacle III
The Joint Commission proposes new pain standards with emphasis on opioid safety — 3 key changes
Sen. John McCain in stable condition after intestinal surgery — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.